Analisi sito web beigene.com
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Generato il Marzo 16 2026 20:57 PM
Statistiche non aggiornate? AGGIORNA !
Il punteggio e 54/100
SEO Content
Title
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Lunghezza : 65
Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Description
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Lunghezza : 171
Idealmente, la tua meta description dovrebbe contenere tra 70 e 160 caratteri (spazi inclusi). Usa questo strumento free per calcolare la lunghezza del testo.
Keywords
Molto male. Non abbiamo trovato meta keywords nella tua pagina. Usa questo generatore gratuito online di meta tags per creare keywords.
Og Meta Properties
Buono, questa pagina sfrutta i vantaggi Og Properties.
| Proprieta | Contenuto |
|---|---|
| locale | en_US |
| type | website |
| title | Advancing Cancer Care Through Science & Purpose | BeOne Medicines |
| description | BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide. |
| url | https://beonemedicines.com/ |
| site_name | BeOne |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 7 | 1 | 16 | 0 | 14 |
- [H1] Transforming How The World Fights Cancer
- [H2] Leading Cancer Research Worldwide
- [H2] Driving Change for People With Cancer
- [H2] BeOne News
- [H2] Be You. Be Change. BeOne.
- [H2] Participate in Research
- [H2] EXTERNAL LINKS
- [H2] EXTERNAL LINKS
- [H3] Discover our nearly 50 abstracts at ASH 2025.
- [H4] Living with Cancer: Richard’s Story
- [H4] Living with Cancer: Geoff and Tina’s story
- [H4] Building a Breast Cancer Pipeline With Purpose
- [H4] A Culture That Enables Innovation
- [H4] BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting…
- [H4] BeOne Medicines to Present at Upcoming Investor Conferences
- [H4] BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results…
- [H4] BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare…
- [H4] ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+…
- [H4] BeOne Medicines’ Novel BCL2 Inhibitor, Sonrotoclax, Achieves First-in-World Approval in R/R MCL…
- [H4] BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
- [H4] BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment…
- [H4] BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic…
- [H4] Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
- [H4] U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed…
- [H4] BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
- [H6] February 26, 2026
- [H6] February 17, 2026
- [H6] February 11, 2026
- [H6] January 13, 2026
- [H6] January 6, 2026
- [H6] January 6, 2026
- [H6] December 23, 2025
- [H6] December 18, 2025
- [H6] December 8, 2025
- [H6] December 7, 2025
- [H6] November 26, 2025
- [H6] November 20, 2025
- [H6] Careers
- [H6] Clinical Trials
Images
Abbiamo trovato 14 immagini in questa pagina web.
Buono, molte o tutte le tue immagini hanno attributo alt
Text/HTML Ratio
Ratio : 11%
Il rapporto testo/codice HTML di questa pagina e inferiore a 15 percento, questo significa che il tuo sito web necessita probabilmente di molto piu contenuto.
Flash
Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Iframe
Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.
SEO Links
URL Rewrite
Buono. I tuoi links appaiono friendly!
Underscores in the URLs
Perfetto! Non sono stati rilevati underscores nei tuoi URLs.
In-page links
Abbiamo trovato un totale di 82 links inclusi 0 link(s) a files
| Anchor | Type | Juice |
|---|---|---|
| Contact Us | Interno | Passing Juice |
| Adverse Events | Interno | Passing Juice |
| Newsroom | Interno | Passing Juice |
| Corporate Press Kit | Interno | Passing Juice |
| Product & Pipeline Media Resources | Externo | Passing Juice |
| Media Library | Interno | Passing Juice |
| Global | Interno | Passing Juice |
| Argentina | Externo | Passing Juice |
| Australia | Externo | Passing Juice |
| Austria | Externo | Passing Juice |
| Brazil | Externo | Passing Juice |
| EN | Externo | Passing Juice |
| FR | Externo | Passing Juice |
| China | Externo | Passing Juice |
| Denmark | Externo | Passing Juice |
| Finland | Externo | Passing Juice |
| France | Externo | Passing Juice |
| Germany | Externo | Passing Juice |
| Italy | Externo | Passing Juice |
| Japan | Externo | Passing Juice |
| MENA | Externo | Passing Juice |
| Netherlands | Externo | Passing Juice |
| Norway | Externo | Passing Juice |
| Singapore | Externo | Passing Juice |
| South Africa | Externo | Passing Juice |
| South Korea | Externo | Passing Juice |
| Spain | Externo | Passing Juice |
| Sweden | Externo | Passing Juice |
| DE | Externo | Passing Juice |
| FR | Externo | Passing Juice |
| IT | Externo | Passing Juice |
| UK | Externo | Passing Juice |
| United States | Externo | Passing Juice |
| About Us | Interno | Passing Juice |
| Our History | Interno | Passing Juice |
| Leadership | Interno | Passing Juice |
| Our Stories | Interno | Passing Juice |
| Our Offices | Interno | Passing Juice |
| Partnering | Interno | Passing Juice |
| Manufacturing | Interno | Passing Juice |
| Our Medicines | Interno | Passing Juice |
| Research & Development Overview | Interno | Passing Juice |
| Disease Focus Areas: Hematology | Interno | Passing Juice |
| Disease Focus Areas: Solid Tumors | Interno | Passing Juice |
| Pioneering Protein Degradation with CDACs | Externo | Passing Juice |
| Antibody Drug Conjugates | Externo | Passing Juice |
| Pipeline | Interno | Passing Juice |
| Find a Trial | Interno | Passing Juice |
| Becoming an Investigator | Interno | Passing Juice |
| Investigator-Initiated Trial | Interno | Passing Juice |
| BeCollective HCP Network | Interno | Passing Juice |
| Collaborations | Externo | Passing Juice |
| Our Commitment to Patients | Interno | Passing Juice |
| Patient Support Program | Interno | Passing Juice |
| Expanded Access Program | Interno | Passing Juice |
| Cancer & Mental Health | Interno | Passing Juice |
| Global Patient Safety | Interno | Passing Juice |
| Responsibility and Sustainability | Interno | Passing Juice |
| Advancing Global Health | Interno | Passing Juice |
| Empowering Our Colleagues | Interno | Passing Juice |
| Innovating Sustainably | Interno | Passing Juice |
| Operating Responsibly Overview | Externo | Passing Juice |
| Policies & Positions | Interno | Passing Juice |
| Suppliers | Interno | Passing Juice |
| Global Transparency | Interno | Passing Juice |
| Giving Overview | Externo | Passing Juice |
| BeOne Care Foundation | Interno | Passing Juice |
| Independent Medical Education Grants | Interno | Passing Juice |
| Careers | Interno | Passing Juice |
| Our Culture | Interno | Passing Juice |
| Visit our congress hub to learn more | Externo | Passing Juice |
| Contact Us | Interno | Passing Juice |
| Newsroom | Interno | Passing Juice |
| NASDAQ Investors | Externo | Passing Juice |
| HKEX Investors | Externo | Passing Juice |
| SSE Investors | Externo | Passing Juice |
| Medical Information | Externo | Passing Juice |
| NASDAQ Investors | Interno | Passing Juice |
| HKEX Investors | Interno | Passing Juice |
| SSE Investors | Interno | Passing Juice |
| Terms of Use | Interno | Passing Juice |
| Privacy Policy | Interno | Passing Juice |
SEO Keywords
Keywords Cloud
cancer research newsroom beone patients media south world press global
Consistenza Keywords
| Keyword | Contenuto | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| global | 8 |  |
|
|
 |
| cancer | 6 | |
|
|
|
| newsroom | 5 | |
|
|
|
| press | 5 | |
|
|
|
| beone | 4 | |
|
|
|
Usabilita
Url
Dominio : beigene.com
Lunghezza : 11
Favicon
Grande, il tuo sito usa una favicon.
Stampabilita
Non abbiamo riscontrato codice CSS Print-Friendly.
Lingua
Buono. La tua lingua dichiarata en.
Dublin Core
Questa pagina non sfrutta i vantaggi di Dublin Core.
Documento
Doctype
HTML 5
Encoding
Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Validita W3C
Errori : 0
Avvisi : 0
Email Privacy
Attenzione! E stato trovato almeno un indirizzo mail in plain text. Usa antispam protector gratuito per nascondere gli indirizzi mail agli spammers.
Deprecated HTML
Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Suggerimenti per velocizzare
|
Eccellente, il tuo sito web non utilizza nested tables. |
|
Molto male, il tuo sito web utilizza stili CSS inline. |
|
Molto male, il tuo sito web ha troppi file CSS files (piu di 4). |
|
Molto male, il tuo sito web ha troppi file JS (piu di 6). |
|
Perfetto, il vostro sito si avvale di gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Ottimizzazione
XML Sitemap
Grande, il vostro sito ha una sitemap XML.
| https://beonemedicines.com/sitemap_index.xml |
Robots.txt
https://beigene.com/robots.txt
Grande, il vostro sito ha un file robots.txt.
Analytics
Non trovato
Non abbiamo rilevato uno strumento di analisi installato su questo sito web.
Web analytics consentono di misurare l'attività dei visitatori sul tuo sito web. Si dovrebbe avere installato almeno un strumento di analisi, ma può anche essere buona per installare una seconda, al fine di un controllo incrociato dei dati.
PageSpeed Insights
Dispositivo
Categorie
Free SEO Testing Tool
Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web